weightloss
For more than a year, there has been a rising trend in using diabetes drugs such as Ozempic solely for its weight loss effect. As with any medication, there are potential risks of side effects that you may or may not have been aware of initially. For instance, in 2023, American Jaclyn Bjorklund launched legal proceedings against Novo Nordisk and Eli Lilly and Co, the manufacturers of Ozempic and Mounjaro respectively, alleging severe gastrointestinal complications, particularly gastroparesis characterised by a paralysis of the stomach. Ozempic: How a TikTok weight loss trend caused a global di...
Euronews (English)
The weight-loss drug semaglutide - commonly sold under the brand names Ozempic and Wegovy - reduced cardiovascular events such as stroke and heart attack in adults with preexisting disease independent of weight loss. It also helped people keep their weight down for at least four years. That is according to two new analyses of a large trial presented at the European Congress on Obesity in Venice on Monday. Semaglutide is the main active ingredient in the popular weight-loss jabs Ozempic and Wegovy. It mimics the GLP-1 hormone which can signal that your body is full. The analyses looked at the S...
Euronews (English)
The company reported a net profit of DKK 25.41 billion (€3.404 billion), up from DKK 19.81 billion (€2.654 billion) in the same period last year and surpassing the DKK 23.09 billion (€3.093 billion) anticipated by analysts. Earnings per share (EPS) also rose to DKK 5.68 (€0.76) from DKK 4.39 (€0.589) a year prior, indicating a robust 8.75% surprise over market expectations. Sales for the quarter reached DKK 65.35 billion (€8.747 billion), a 22% increase from DKK 53.37 billion (€7.135 billion) a year ago, outperforming the DKK 63.43 billion (€8.490 billion) forecast by analysts. Weight-loss dru...
Euronews (English)
No, smoking will not keep you thin. A recent study by researchers at the University of Copenhagen has debunked the oft-cited myth that smoking will help you to keep off the pounds. Instead, the study, which looked at one and a half million Europeans who smoked, found that smoking actually increases belly fat. No, Ursula von der Leyen’s grandfather was not an SS generalMost adults in England wrongly think vaping is worse or as bad as smoking - studyWas the captain of the ship that hit the Baltimore bridge Ukrainian?It’s quite well-documented that when people stop smoking, their bodies start bur...
Euronews (English)
Pharmaceutical giant Novo Nordisk is to take over German biotech company Cardior Pharmaceuticals in a deal worth up to €1.025 billion. The latter, which works mainly on cardiovascular cures, will lay the foundation for Novo Nordisk to expand into the heart disease sector. Novo Nordisk, of weight loss drug Wegovy and diabetes drug Ozempic fame, recently became Europe's biggest company, with a market capitalisation of about DKK 3.05 trillion (€0.41 trillion). The company also accounts for almost 50% of global insulin production. At the time of writing, the company's shares were trading at around...
Euronews (English)
Pharmaceutical giant Novo Nordisk has recently overtaken electric vehicle maker Tesla, in terms of market valuation, following upbeat initial trial data for a new obesity drug. Novo Nordisk, already well known for the popular obesity drug Wegovy, had a market valuation of about $566 billion (€517.6 billion), on Thursday, as shares rose about 8%. That is more than companies such as Tesla and Visa, according to London Stock Exchange Group (LSEG) data. It also surpassed LVMH as Europe's biggest company in terms of market valuation last year. Following the launch of Wegovy in June 2021, Novo Nordi...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら